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Abstract: Recombination in the family Coronaviridae has been well documented and is 
thought to be a contributing factor in the emergence and evolution of different coronaviral 
genotypes as well as different species of coronavirus. However, there are limited data 
available on the frequency and extent of recombination in coronaviruses in nature and 
particularly for the avian gamma-coronaviruses where only recently the emergence of a 
turkey coronavirus has been attributed solely to recombination. In this study, the full-length 
genomes of eight avian gamma-coronavirus infectious bronchitis virus (IBV) isolates were 
sequenced and along with other full-length IBV genomes available from GenBank were 
analyzed for recombination. Evidence of recombination was found in every sequence 
analyzed and was distributed throughout the entire genome. Areas that have the highest 
occurrence of recombination are located in regions of the genome that code for 
nonstructural proteins 2, 3 and 16, and the structural spike glycoprotein. The extent of the 
recombination observed, suggests that this may be one of the principal mechanisms for 
generating genetic and antigenic diversity within IBV. These data indicate that reticulate 
evolutionary change due to recombination in IBV, likely plays a major role in the origin 
and adaptation of the virus leading to new genetic types and strains of the virus. 
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1. Introduction 
Avian infectious bronchitis virus (IBV) is a gamma-coronavirus in the family Coronaviridae, the 
order Nidovirales, and the genus Coronavirus that causes a highly contagious upper-respiratory disease 
of domestic chickens. In layer type birds it can cause a drop in egg production and some strains are 
nephropathogenic. Infectious bronchitis remains one of the most widely reported respiratory diseases 
of chickens worldwide despite the routine usage of attenuated live vaccines to control the disease. 
Control of IBV is difficult because there is little to no cross-protection between the numerous different 
serotypes of the virus. 
Infectious bronchitis virus is an enveloped, single-stranded, positive-sense RNA virus with a 
genome length of approximately 27 kb. The 3' end of the genome encodes four structural proteins; 
spike (S), envelope (E), membrane (M) and nucleocapsid (N) as well as several non-structural 
proteins  [1]. The S glycoprotein of IBV forms projections on the surface of the virion. Spike is 
post-translationally cleaved into S1 and S2 subunits with the S1 subunit forming the outermost portion 
and S2 forming a stalk-like structure that is embedded in the viral membrane. The S1 subunit contains 
hypervariable regions that play a role in attachment to host cell receptors, and it contains 
conformationally-dependent virus-neutralizing and serotype-specific epitopes [2,3]. Spike is also 
involved in membrane fusion and viral entry into the host cell. The E and M proteins are integral 
membrane proteins involved in assembly of the virus. The N protein is closely associated with the viral 
genome and plays a role in replication. The 5' two-thirds of the genome, approximately 21 kb, encodes 
two polyproteins 1a and 1ab. A minus one frame-shift mechanism is used to translate the 1ab 
polyprotein. The polyproteins are post-translationally cleaved into 15 non-structural proteins (nsps), 
nsp 2–16 (IBV does not have an nsp1) that make up the replication complex. Key nsps encoded, 
include a papain-like protease 2 (PLP2) within nsp 3, a main protease (Mpro) within nsp 5, and the 
RNA-dependent RNA-polymerase (RdRp) within nsps 11 and 12.  
Genetic diversity in coronaviruses is due to adaptive evolution driven by high mutation rates and 
genetic recombination [4]. High mutation rates are attributed to minimal proof reading capabilities 
associated with the RdRp. Recombination is thought to be due to a unique template switching 
“copy-choice” mechanism during RNA replication [5]. Evidence of recombination among strains of 
IBV has been observed both experimentally and in the field [6–11]. The emergence of several 
alpha- and beta-coronaviruses has been attributed to recombination [12,13] but only recently was 
recombination shown to be the mechanism behind the emergence of a novel gamma-coronavirus, 
turkey coronavirus (TCoV) [14]. Although “hot spots” of recombination in the genome of IBV have 
been reported [9,15], a thorough study of recombination using multiple different strains across the 
entire genome has not been conducted.  
In this study we sequenced and analyzed the entire genome of eight IBV strains that represent 
different serotypes that have not been previously sequenced, and we compared these sequences with Viruses 2011, 3              
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other gamma-coronavirus full-length genome sequences available in GenBank for evidence of 
recombination [16]. Different serotypes of field viruses and vaccine type viruses were selected to provide 
a wide variety of sequences potentially capable of contributing gene fragments to recombinants. 
2. Results and Discussion 
2.1. Sequence Analysis 
The full-length genomes of eight isolates of IBV were sequenced at 5× to 10× coverage, and the 
consensus sequences were assembled. The genome size (see the end of the 3'UTR in Table 1), 
organization of the genome, and the location and size of the open reading frames (ORFs) are listed in 
Table 1 for each of the viruses. The gene order is the same for all the viruses examined; 
5'UTR-1a/ab-spike-3a-3b-Envelope-Membrane-4b-4c-5a-5b-Nucleocapsid-3'UTR. In addition, the 
genomes for CAV/CAV56b/91, DE/DE072/92, FL/FL18288/71, Mass/H120, Iowa/Iowa97/56 and 
JMK/JMK/64 contain ORF 6b between nucleocapsid and the 3'UTR.  
The full-length genomes were aligned and phylogenetic trees were constructed using the 
Neighbor-joining, Minimum Evolution, Maximum Parsimony and UPGMA programs in MEGA4 [17]. 
The trees all had similar topology and bootstrap support, and a representative tree is shown in Figure 1. 
The feline coronavirus FCoV/FIPV/WSU-79-1146 and the beluga whale virus BelugaWhaleCoV/SW1/08 
were included as out-groups. The wild bird viruses isolated from a munia (MuniaCoV/HKUY13/09), 
thrush (ThrushCoV/HKU12/09) and bulbul (BulBulCoV/HKU11/09) formed a unique clade, which is 
not surprising as this group might represent a new coronavirus genus provisionally designated 
Deltacoronavirus [18]. The remaining viruses separated into clades consisting of IBV isolates from the 
US and vaccine viruses, TCoV isolates, an IBV isolate from West Africa and IBV isolates from China 
and Taiwan.  
Vaccines for IBV used in commercial poultry include the serotypes Mass, Conn, DE and Ark. The 
PeafowlCcV/GD/KQ6/03, CK/CH/LSD/051/06 and CK/CH/ZJ971/97 strains from China grouped 
with Mass type viruses indicating that they are closely related, which is not surprising since Mass type 
vaccines are used in China. The overall percent similarities between the various strains are listed in 
Supplemental Table 1. All IBV genomes examined are greater than 80% similar at the nucleotide level. 
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Table 1. Genes and coding regions for eight strains of avian infectious bronchitis virus examined in this study. 
ORF
a 
CAV/CAV56b/91 DE/DE072/92 FL/FL18288/71  Gray/Gray/60 Mass/H120  Holte/Holte/54  Iowa/Iowa97/56  JMK/JMK/64 
Location nt
b aa
c  Location nt aa  Location nt aa  Location nt aa  Location nt aa  Location nt  aa  Location nt aa  Location nt  aa 
5'UTR  1–527  527 –  1–528 528  –  1–528 528  –  1–528 528  –  1–528 528  –  1–528 528 –  1–528 528  –  1–528 528 – 
1a  528–12389 1,862  3953 
529–
12309 
11781 3926 
529–
12387 
11859 3952 
529–
12387 
11859 3952 
529–
12330 
11802 3933 
529–
12384 
11856 3951 
529–
12390 
11802 3933 
529–
12387 
11859 3952 
1ab  528–20422 19895  6631 
529–
20336 
19808 6602 
529–
20420 
19892 6630 
529–
20420 
19892 6630 
529–
20363 
19835 6611 
529–
20414 
19886 6628 
529–
20423 
19895 6631 
529–
20421 
19893 6630 
Spike 
20373–
23873 
3501 1166 
20287–
23739 
3453 1150 
20371–
23838 
3468 1155 
20371–
23874 
3504 1167 
20314–
23802 
3489 1162 
20365–
23871 
3507 1168 
20374–
23880 
3507 1168 
20371–
23877 
3507 1168 
3a 
23873–
24046 
174 57 
23785–
23958 
174 57 
23838–
24011 
164 54 
23874–
24047 
174 57 
23802–
23975 
174 57 
23871–
24044 
174 57 
23880–
24053 
174 57 
23877–
24050 
174 57 
3b 
24046–
24240 
195 64 
23958–
24152 
195 64 
24011–
24202 
192 63 
24047–
24241 
195 64 
23975–
24169 
195 64 
24044–
24238 
195 64 
24053–
24247 
195 64 
24050–
24244 
195 64 
Envelope 
24221–
24502 
282 93 
24133–
24462 
330 109 
24186–
24488 
303 100 
24222–
24545 
324 107 
24150–
24479 
330 109 
24219–
24542 
324 107 
24228–
24551 
324 107 
24225–
24548 
324 107 
Membrane 
24651–
25175 
525 174 
24434–
25111 
678 225 
24488–
25156 
669 222 
24523–
25188 
666 221 
24451–
25128 
678 225 
24520–
25188 
667 222 
24529–
25140 
612 203 
24526–
25197 
672 223 
4b 
25176–
25460 
285 94 
25112–
25396 
285 94 
25157–
25441 
285 94 
25189–
25428 
240 79 
25129–
25371 
243 80 
25189–
25473 
285 94 
25194–
25478 
285 94 
25198–
25329 
132 43 
4c 
25381–
25554 
174 57 
25317–
25487 
171 56 
25362–
25532 
171 56 
25340–
25510 
171 56 
25334–
25504 
171 56 
25394–
25534 
141 46 
25399–
25539 
141 46 
25374–
25568 
195 64 
5a 
25538–
25735 
198 65 
25471–
25668 
198 65 
25516–
25713 
198 65 
25494–
25691 
198 65 
25488–
25685 
198 65 
25547–
25744 
198 65 
25552–
25749 
198 65 
25552–
25749 
198 65 
5b 
25732–
25980 
249 82 
25665–
25913 
249 82 
25710–
25958 
249 82 
25688–
25936 
249 82 
25682–
25930 
249 82 
25741–
25989 
249 82 
25746–
25994 
249 82 
25746–
25994 
249 82 
Nucleocapsid 
25923–
27152 
1230 409 
25856–
27085 
1230 409 
25901–
27130 
1230 409 
25879–
27111 
1233 410 
25873–
27102 
1230 409 
25932–
27161 
1230 409 
25937–
27166 
1230 409 
25937–
27166 
1230 409 
6b 
27161–
27385 
225 74 
27094–
27318 
225 74 
27139–
27363 
225 74  –  –  – 
27126–
27356 
231 76  –  –  – 
27175–
27399 
225 74 
27175–
27399 
225 74 
3'UTR 
27386–
27663 
248 – 
27319–
27591 
273 – 
27364–
27616 
253 – 
27112–
27568 
455 – 
27357–
27632 
276 – 
27162–
27246 
85 – 
27340–
27662 
323 – 
27400–
27793 
393 – 
a ORF = open reading frame; 
b nt = nucleotide; 
c aa = amino acid. V
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genomes available in the database for CK/CH/EP3, CK/CH/p65, and Mass/Beaudette were excluded 
from the analysis because they are viruses not found in the field. The recombination programs can be 
used to detect recombination without reference sequences, and our analysis was conducted without 
regard to date of isolation because that information was not available for some of the viruses. Although 
the programs attempt to identify major and minor parent sequences contributing to each recombinant, 
the data reported herein only represents sequences in other viruses that are most closely related to the 
sequence surrounding the transferred fragment (major sequence) and the sequence closely related to 
the transferred fragment (minor sequences) and doesn’t imply origin or source of the transferred 
fragment. In many cases, the transferred fragment has undergone mutations making it difficult to 
identify all the endpoints for the major and minor sequences. In addition, some of the transferred 
fragments overlap suggesting that recombinations have occurred between recombinant viruses. 
Twenty-five IBV strains were examined and the viruses with the most transferred fragments in 
Table 2 are CAV/56b/91 and Mass/H52 both with 8 fragments, and CK/CH/LSD/051/06 and 
GA98/0470/98 both with 7 fragments. The strains with the fewest transferred fragments are 
Iowa/Iowa97/56 and TW/2575/98 with only 2 transferred fragments and the CK/CH/BJ/97, 
Holte/Holte/54, and NGA/A116E7/06 strains with only 1 transferred fragment. The Ark/Ark-DPI-p11/81 
and Ark/Ark-DPI-p101/81 strains are the same virus that was passaged 11 and 101 times in 
embryonated eggs, respectively. Both viruses share identical transferred fragments indicating that they 
have identical recombination history. In addition, Conn/Conn46/66 and Conn/Conn46/91 share the 
same recombination history (4 identical transferred fragments). The Conn/Conn46/66 field virus was 
used to produce an attenuated live vaccine, which is currently used in commercial poultry. Viruses that 
share the same recombination history are likely derived from the same parent virus suggesting that 
Conn/Conn46/91 is reisolated Conn vaccine derived from the Conn/Conn46/66 virus. The 
FL/FL18288/71 virus also shares all 4 transferred fragments with the Conn viruses,   
however; FL/FL18288/71 and Conn viruses are different serotypes suggesting that FL/FL18288/71  
is a field virus that emerged due to point mutations accumulating in spike over time rather than   
from recombination.  
All 6 of the transferred fragments in CK/CH/ZJ971/97 are identical to all 6 of the transferred 
fragments in vaccine strain Mass/H120, providing compelling evidence that CK/CH/ZJ971/97 is 
reisolated Mass/H120 vaccine. That observation was also reported by Zhang et al. [23]. It is interesting 
that Mass/H52 (8 transferred fragments) and Mass/H120 (6 transferred fragments) share only 5 
identical transferred fragments. The Mass/H52 and Mass/H120 viruses were isolated circa 1955 in the 
Netherlands and it is widely accepted that H stands for Holland, but it actually stands for Houben, the 
owner of the broiler farm where the viruses were isolated [24]. It is thought that Mass/H120 was 
derived from Mass/H52 but the actual relationship between the viruses is not certain. Our data 
indicates that they are not necessarily parent and progeny but they are closely related. 
The Gray/Gray/60 and JMK/JMK/64 viruses share 99.7% nucleotide similarity across the entire 
genome and have 4 identical transferred fragments with JMK/JMK/64 having one additional fragment 
located in the 5'UTR, which is not found in Gray/Gray/60. It is well known that the Gray/Gray/60 virus 
is nephropathogenic, whereas the JMK/JMK/64 virus is strictly respirotropic. Perhaps sequence 
differences in the 5'UTR, which is involved in replication of the viral genome, play a role in the 
different pathobiologies observed for these viruses.  Viruses 2011, 3              
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Table 2. Recombination breakpoints 
a, genes and major and minor related sequences in other infectious bronchitis virus (IBV) strains. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
Ark/Ark-DPI-
11/81  3,498  8,667  1ab (nsp 3, 4, and 5)  Conn/Conn46/66  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16) 
Unknown
e 
(JMK/JMK/64)  CAL/CAL99/99 RDP,  GENECONV,  Maxchi, Chimaera, SiSscan, 3Seq 
  20,292  23,909  1ab (nsp16), Spike, 3a  Conn/Conn46/66  Unknown 
(Mass/Mass41)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 21,613  23,856*  Spike,  3a  CAL/CAL99/99  JMK/JMK/64  RDP, Maxchi, Chimaera, SiSscan, 3Seq 
Ark/Ark-DPI-
101/81  3,498  8,667  1ab (nsp 3, 4, and 5)  Conn/Conn46/66  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  20,292  23,909  1ab (nsp16), Spike, 3a  Conn/Conn46/66  Unknown 
(Mass/Mass41)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 21,613  23,856*  Spike,  3a  CAL/CAL99/99  JMK/JMK/64  RDP, Maxchi, Chimaera, SiSscan, 3Seq 
CAL/CAL99/
99  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 2,382  4,255*  1ab  (nsp2,nsp3)  DE/DE072/92  Conn/Conn46/66  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  8,104  10,649*  1ab (nsp 4, 5, and 6)  DE/DE072/92  Conn/Conn46/66  RDP, Maxchi, Chimaera, SiSscan, 3Seq 
 24,587*  25,773  Envelope, Membrane, 4b, 4c, 
5a, 5b  Unknown (GA/GA98/98)  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
CAV/56b/91  0*  1,512  1ab (nsp 2)  ITA/90254/2005  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,392*  4,558  1ab (nsp3)  Ark/Ark-DPI/81  Conn/Conn46/91  GENECONV, Maxchi, Chimaera, 3Seq 
  8,104  10,649*  1ab (nsp 4, 5, and 6)  DE/DE072/92  Conn/Conn46/66  RDP, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  20,292  23,909  1ab (nsp16), Spike, 3a  Conn/Conn46/66  Unknown 
(Mass/Mass41)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 24,556  25,748  Envelope, Membrane, 4b, 4c, 
5a, 5b  Ark/Ark-DPI/81  Unknown 
(CAL/CAL99/99)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq Viruses 2011, 3              
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Table 2. Cont. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
CK/CH/BJ/97  31*  5,600  5'UTR, 1ab (nsp 2 and 3)  CK/CH/SAIBK  Unknown 
(CK/CH/CQ041/04)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
CK/CH/CQ04
-1/04  60*  4,711  5'UTR, 1ab (nsp 2 and 3)  CK/CH/SC021202/02  CK/CH/DY-07/07  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  8,751  9,018  1 ab (nsp 5)  CK/CH/SC021202/02  CK/CH/DY-07/07  RDP, GENECONV, Maxchi, Chimaera 
 9,626  18,737  1ab (nsp 5, 6, 7, 8, 9, 10, 
11/12, 13, 14, 15)  CK/CH/SAIBK CK/CH/DY-07/07  RDP,  GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  18,738*  20,350  1ab (nsp 15 and 16)  CK/CH/SAIBK  ITA/90254/2005  RDP, GENECONV, Maxchi, Chimaera 
  20,160  21,138  1ab (nsp 16), Spike  JMK/JMK/64  CK/CH/BJ/97  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  27,120  27,354  Nucleocapsid, 6b  JMK/JMK/64  CK/CH/DY-07/07  GENECONV, Maxchi, Chimaera, SiSscan 
CK/CH/DY-
07/07  1,170  5,017  1ab (nsp 2 and 3)  DE/DE072/92  CK/CH/SAIBK  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 22,216  23,963  Spike,  3a  CK/CH/BJ/97  CK/CH/CQ04-1/04  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  25,455  25,662  4c, 5a  CK/CH/BJ/97  CK/CH/CQ04-1/04  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
CK/CH/LSD/0
51/06  306  3,628*  5'UTR, 1ab (nsp 2 and 3)  Mass/Mass41  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  1,453  2,743  1ab (nsp 2 and 3)  Mass/H52  Mass/Mass41/41  GENECONV, Maxchi, Chimaera, 3Seq 
  13,668  14,734  1ab, (nsp 11/12)  Mass/Mass41/41  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 15,447  15,821  1ab  (nsp  13)  Mass/Mass41/41  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
 20,203  24,772  1ab (nsp 16), Spike, 3a, 3b, 
Envelope, Membrane  NGA/A116E7/06  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  25,063  25,776  Membrane, 4b, 4c, 5a, 5b  Unknown 
(Mass/Mass41/41)  Mass/H120 RDP,  GENECONV,  Maxchi, Chimaera, SiSscan, 3Seq 
  25,774*  26,341  5b, Nucleocapsid  Mass/Mass41/41  Mass/H120  RDP, GENECONV, SiSscan, 3Seq 
CK/CH/SAIB
K  7,241  9,126  1ab (nsp 3, 4,5)  CK/CH/SC0212/02  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  20,160  21,138  1ab (nsp 16), Spike  JMK/JMK/64  CK/CH/BJ/97  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
CK/CH/SC02
1202/02  13,342 14,784  1ab  (nsp  11/12)  CK/CH/SAIBK  CK/CH/DY-07/07  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  20,160  21,138  1ab (nsp 16), Spike  JMK/JMK/64  CK/CH/BJ/97  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  27,120  27,354  Nucleocapsid, 6b  JMK/JMK/64  CK/CH/DY-07/07  GENECONV, Maxchi, Chimaera, SiSscan Viruses 2011, 3              
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Table 2. Cont. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
CK/CH/ZJ971
/97  0* 11,115  5'UTR, 1ab (nsp 2, 3, 4, 5, 6, 
7, and 8)  NGA/A116E7/06  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  306  3,628*  5'UTR, 1ab (nsp 2 and 3)  Mass/Mass41  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,203  24,772  1ab (nsp 16), Spike, 3a, 3b, 
Envelope, Membrane  NGA/A116E7/06  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  26,286  27,027  Nucleocapsid, 6b, 3'UTR  Iowa/Iowa97/56  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
 27,094  27,244  Nucleocapsid,  6b  Iowa/Iowa97/56  Unknown 
(TW/2575/98)  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
Conn/Conn46/
66  0*  1,512  1ab (nsp 2)  ITA/90254/2005  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,361  21,981  Spike  CAL/CAL99/99  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
Conn/Conn46/
91  0*  1,512  1ab (nsp 2)  ITA/90254/2005  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,361  21,981  Spike  CAL/CAL99/99  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
DE/DE072/92 0*  11,115  5'UTR, 1ab (nsp 2, 3, 4, 5, 6, 
7, and 8)  NGA/A116E7/06  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  18,776  19,911*  1ab (nsp 15 and 16)  Mass/H120  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 19,934  24,431  1ab (nsp16), Spike, 3a, 3b, 
Envelope  Mass/H120  Unknown 
(Mass/Mass41)  RDP, GENECOV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,203  24,772  1ab (nsp 16), Spike, 3a, 3b, 
Envelope, Membrane  NGA/A116E7/06  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  23,504  24,431*  Spike, 3a, 3b, Envelope  CK/CH/CQ04-1/04  CALCAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 25,575  27,482*  5a, 5b, Nucleocapsid, 6b, 
3'UTR  CK/CH/ZJ971/97  JMK/JMK/64  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq Viruses 2011, 3              
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Table 2. Cont. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
FL/FL18288/7
1  0*  1,512  1ab (nsp 2)  ITA/90254/2005  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,361  21,981  Spike  CAL/CAL99/99  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
GA98/0470/98  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  2,382  4,255*  1ab, (nsp2 and 3)  DE/DE072/92  Conn/Conn46/66  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  3,498  8,667  1ab (nsp 3, 4, and 5)  Conn/Conn46/66  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 9,569  9,770  1ab  (nsp  5)  Gray/Gray/60  Unknown 
(NGA/A116E7/06)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 13,072  20,186  1ab (nsp 11/12, 13, 14, 15, 
and 16)  Unknown (JMK/JMK/64)  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  23,504  24,431*  Spike, 3a, 3b, Envelope  CK/CH/CQ04-1/04  CALCAL99/99  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 24,500*  25,438  Membrane,  4b Conn/Conn46/66  Mass/Mass41/41  RDP, GENECONV, Chimaera, SiSscan, 3Seq 
Gray/Gray/60  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 8,488  12,055  1ab (nsp 4, 5, 6, 7, 8, 9, and 
10) 
Unknown 
(CK/CH/LSD/051/06)  Conn/Conn46/91  RDP, GENECONV, Maxchi, Chimaera 
  13,070*  14,216  1ab (nsp 11/12)  Unknown (CAV/56b/91)  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 24,131  27,145 
3b, Envelope, Membrane, 4b, 
4c, 5a, 5b, Nucleocapsid, 
3'UTR 
Ark/Ark-DPI/81  Unknown 
(Conn/Conn46/91)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
Holte/Holte/54  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
Iowa/Iowa97/
56  0*  4,368  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,368  5,144  1ab (nsp 3)  Holte/Holte/54  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq Viruses 2011, 3              
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Table 2. Cont. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
ITA/90254/05 16,367  25,699 
1ab (nsp 13, 14, 15, 16) 
Spike, 3a, 3b, Envelope, 
Membrane, 4b, 4c, 5a 
GA98/0470/98  CK/CH/BJ/97  RDP, GENCOV, Maxchi, SiSscan 
 22,216  23,963  Spike,  3a  CK/CH/BJ/97  CK/CH/CQ04-1/04  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 24,423  25,632*  Envelope, Membrane, 4b, 4c, 
5a  CK/CH/DY-07/07  NGA/A116E7/06  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
JMK/JMK/64  0*  1,512  1ab (nsp 2)  ITA/90254/2005  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  0*  4,368*  5'UTR,1ab (nsp 2 and 3)  Ark/Ark-DPI/81  Unknown 
(DE/DE072/92)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 8,488  12,055  1ab (nsp 4, 5, 6, 7, 8, 9, and 
10) 
Unknown 
(CK/CH/LSD/051/06)  Conn/Conn46/91  RDP, GENECONV, Maxchi, Chimaera 
  13,070*  14,216  1ab (nsp 11/12)  Unknown (CAV/56b/91)  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 24,131  27,145 
3b, Envelope, Membrane, 4b, 
4c, 5a, 5b, Nucleocapsid, 
3'UTR 
Ark/Ark-DPI/81  Unknown 
(Conn/Conn46/91)  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
Mass/H52  306  3,628*  5'UTR, 1ab (nsp 2 and 3)  Mass/Mass41  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 19,925  20,168*  1ab  (nsp  16)  Mass/Mass41/41  Mass/H120  GENECONV, Maxchi, Chimaera, SiSscan 
 20,203  24,772  1ab (nsp 16), Spike, 3a, 3b, 
Envelope, Membrane  NGA/A116E7/06  Mass/Mass41/41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  25,063  25,776  Membrane, 4b, 4c, 5a, 5b  Unknown 
(Mass/Mass41/41)  Mass/H120 RDP,  GENECONV,  Maxchi, Chimaera, SiSscan, 3Seq 
  26,286  27,027  Nucleocapsid, 6b, 3'UTR  Iowa/Iowa97/56  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
  26,372  27,526*  Nucleocapsid, 6b, 3'UTR  Unknown (DE/DE072/92)  Mass/H120  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 27,094  27,244  Nucleocapsid,  6b  Iowa/Iowa97/56  Unknown 
(TW/2575/98)  RDP, GENECONV, Maxchi, Chimaera, SiSscan Viruses 2011, 3              
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Table 2. Cont. 
Recombinant  Breakpoints  Genes 
b  Major Sequence 
c  Minor Sequence 
d  Detection Method  Begin End 
Mass/H120 0*  11,115  5'UTR, 1ab (nsp 2, 3, 4, 5, 6, 
7, and 8)  NGA/A116E7/06  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  306  3,628*  5'UTR, 1ab (nsp 2 and 3)  Mass/Mass41  Ark/Ark-DPI/81  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  4,312  10,590  1ab (nsp 3, 4, 5, and 6)  CK/CH/LSD/051  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
 20,203  24,772  1ab (nsp 16), Spike, 3a, 3b, 
Envelope, Membrane  NGA/A116E7/06  Mass/Mass41  RDP, GENECONV, Maxchi, Chimaera, SiSscan, 3Seq 
  26,286  27,027  Nucleocapsid, 6b, 3'UTR  Iowa/Iowa97/56  CAL/CAL99/99  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
 27,094  27,244  Nucleocapsid,  6b  Iowa/Iowa97/56  Unknown 
(TW/2575/98)  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
NGA/A116E7
/06  7,035  8,271  1ab (nsp 3 and 4)  Holte/Holte/54  DE/DE072/92  RDP, GENECONV, Maxchi, Chimaera, 3Seq 
TW/2575/98  20,160  21,138  1ab (nsp 16), Spike  JMK/JMK/64  CK/CH/BJ/97  RDP, GENECONV, Maxchi, Chimaera, SiSscan 
  27,120  27,354  Nucleocapsid, 6b  JMK/JMK/64  CK/CH/DY-07/07  GENECONV, Maxchi, Chimaera, SiSscan 
* The actual breakpoint position is undetermined. Most likely it was overprinted by a subsequent recombination event. 
a Only transferred gene fragments 
with statistical support of >1 × 10
−12 (50 of 135 total unique fragments) are included in the table. 
b Genes indicate the coding sequences contained within 
the fragment introduced by recombination. 
c Major Sequence = Sequence most closely related to the sequence surrounding the transferred fragment.  
d Minor Sequence = Sequence closely related to the transferred fragment in the recombinant. 
e Unknown = only one parent and a recombinant need be in 
the alignment for a transferred fragment to be detectable. The sequence listed in parentheses was used to infer the existence of a missing parental sequence.  
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There is evidence that some transferred fragments in field viruses come from vaccines. As an 
example, CK/CH/LSD/051/06 has 3 of 7 and 2 of 7 transferred fragments in common with vaccine 
strains Mass/H52 and Mass/H120, respectively. In addition, the only fragments that USA viruses have 
in common with the viruses from China and Taiwan are fragments also associated with Mass type 
vaccines, which are used in both regions, providing further evidence that some of the fragments in 
field viruses come from vaccines. That result and the observation in Figure 1 that the viruses separated 
into clades based on geographic location also supports the conclusion that USA viruses have not 
recombined with Asian viruses.  
A difference in the order of taxa in phylogenetic trees constructed from different regions of the 
genome is further evidence of recombination [25]. The ordering of taxa in sequential trees [26,27] was 
conducted and inconsistent phylogenetic relationships were observed for all of the examined virus 
strains across the entire genome, indicating a substantial amount of recombination (data not shown). 
There is a high number of breakpoints in the 1a region of the genome and immediately upstream of the 
S gene, which has been previously shown to be a ‘hot spot’ for recombination [9]. A phylogenetic 
compatibility matrix constructed at the 70% bootstrap level for 250 bp sequence fragments at 100 bp 
intervals also showed that recombination breakpoints were distributed throughout the IBV genomes 
(data not shown).  
To determine recombination hot and cold spots, a recombination breakpoint distribution plot 
(Figure 3) was generated in RDP4 using a 200 nt window and 1,000 permutations [21]. No global 
hot-spot regions were observed in the 95% and 99% confidence thresholds (dotted lines at the top of 
the graph). The detectable recombination breakpoint positions are shown at the top of the figure and 
were distributed throughout the genome with a relatively high number clustered just upstream of the S 
gene. That region also had the highest breakpoint count within the 99% local hot/cold-spot confidence 
interval. A high number of breakpoints were also observed in the 1a region of the genome; nsp 2, 
nsp 3, and nsp 16, in the envelope and matrix protein genes and in a small area near the 3'UTR. 
Table 3 shows that nsp2, nsp3, nsp16 and spike genes were associated with the greatest number of 
transferred fragments, which is consistent with the location and number of breakpoints in Figure 3. 
Recombination in the 1ab ORF area, which encodes the nonstructural proteins involved in the viral 
replication complex, has the potential to alter the pathogenicity of the virus [28]. The nsp 2 contains 
hydrophobic residues that likely anchor the replication complex to the Golgi [29]. The nsp 3 encodes 
the protease PLP2 which cleaves nsps 2, 3, and 4 and an area with ADP-ribose 1'-phosphatase (ADRP) 
activity. The protease PLP2 has been shown to have deubiquinating-like activity [30] and also to be a 
type I interferon (IFN) antagonist [31]. Changes in the amino acid composition of this area could affect 
the ability of the virus to replicate in a variety of cell types. The ADRP region of nsp 3 is conserved 
among coronaviruses [32,33], and a recent study suggested a biological role for the coronavirus ADRP 
in modulating the expression of pro-inflammatory immune modulators such as tumor necrosis factor 
alpha and interleukin-6 [34]. Recombination in this area could alter the pathogenicity of the virus by 
modulating host cytokine expression. The nsp16 is reported to be an S-adenosyl-L-methionine 
(AdoMet)-dependent RNA (nucleoside-2'O)-methyltransferase (2'O-MTase) responsible for capping 
the viral mRNA nascent transcripts [32]. An alteration in the efficiency of this protein could 
profoundly decrease not only viral replication but also pathogenicity. The spike glycoprotein of IBV 
on the surface of the virus plays a role in attachment to host cell receptors, membrane fusion and entry V
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Table 3. Number of transferred fragments associated with individual areas of the genome 
for all of the strains examined. 
Genomic Region  Number of Fragments 
a  % of Total
 
5'UTR 
b  8 4.2 
Nsp 
c 2  20  10.5 
nsp 3  33  17.3 
nsp 4  17  8.9 
nsp 5  15  7.9 
nsp6 10  8.3 
nsp 7  6  3.2 
nsp 8  6  3.2 
nsp9 4  2.1 
nsp 10  4  2.1 
nsp 11/12  13  6.8 
nsp 13  12  6.3 
nsp 14  10  5.3 
nsp 15  10  5.3 
nsp 16  19  10.0 
Spike 30  15.8 
3a 14  7.4 
3b 13  6.8 
Envelope 17 8.9 
Membrane 17  8.9 
4b 12  6.3 
4c 12  6.3 
5a 15  7.9 
5b 11  5.8 
Nucleocapsid 14  7.4 
3'UTR 13  6.8 
a Genomic areas may be fully or only partially located in the transferred fragments.   
b UTR = untranslated region. 
c nsp = nonstructural protein. 
3. Conclusions 
In this study, evidence was obtained that recombination is occurring among avian coronavirus IBV 
isolates across their entire genome. Every sequence included in the analysis was recognized as a 
potential recipient of horizontally acquired sequences at some point in its viral evolutionary past. The 
nsp2, nsp3, nsp16 were associated with the greatest number of transferred fragments. In addition, the 
area immediately upstream of the spike gene had the highest number of recombination breakpoints. 
Breakpoints in the 1ab polyprotein gene have the potential to alter pathogenicity of the virus, and 
breakpoints near or in spike have the potential to lead to the emergence of new serotypes of IBV or 
new coronaviruses. Although the spike region determines the serotype of the virus, the remainder of 
the genome may be a mosaic of sequence fragments from a variety of gamma-coronaviruses. The only 
evidence of a gamma-coronavirus possibly recombining with an alpha or beta-coronavirus was the Viruses 2011, 3              
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discovery of the mosaic nature of the SARS-coronavirus genome [35]. Although this type of 
recombination is possible it appears to be rare in nature.  
In this study, we characterized recombination in the full-length genomes of avian gamma-
coronavirus IBV strains from around the world. Our bioinformatic analysis was similar to a previous 
study on enteroviruses [36] and we found that recombination in IBV is more extensive than formerly 
thought, involving regions across the entire genome. Our data suggests that reticulate evolution due to 
a high frequency of recombination in IBV, likely plays a major role in the generation of new serotypes 
of the virus. The characterization, distribution and frequency of recombination breakpoints are 
important information that will further our understanding of the mechanisms behind the diversity and 
evolution of these viruses so that better control methods can be developed. 
4. Materials and Methods 
4.1. Viruses and Viral RNA Extraction 
All of the viruses sequenced in this study (Table 4), were propagated in 9–11 day-old 
specific-pathogen-free (SPF) embryonated eggs as described [37]. Total RNA was isolated from 
200 μL of allantoic fluid collected from the infected eggs using the High Pure RNA Isolation Kit 
(Roche Applied Science, Mannheim, Germany) following the manufacturer’s instructions. 
Table 4. Viruses sequenced in this study. 
Strain Serotype  Origin  Source 
CAV/CAV56b/91  CAV California,  USA  P.  Woolcock 
a 
DE/DE072/92  DE  Delmarva, USA  J. Gelb Jr 
b 
FL/FL18288/71  FL  Florida, USA  P. Villegas 
c 
Gray/Gray/60  Gray  Delmarva, USA  J. Gelb Jr. 
Holte/Holte/54  Holte  Wisconsin, USA  J. King 
d 
Iowa/Iowa97/56  Iowa  Iowa, USA  J. King 
JMK/JMK/64  JMK  Delmarva, USA  J. Gelb, Jr. 
Mass/H120  Mass  The Netherlands  J. King 
a University of California, Davis, CA, USA. 
b University of Delaware, Newark, DE, USA.   
c University of Georgia, Athens, GA, USA. 
d Southeast Poultry Research Laboratory, USDA/ARS, 
Athens, GA, USA. 
4.2. RT-PCR Amplification and Sequencing 
The amplification reactions were carried out using strand displacement RT-PCR or one step   
RT-PCR. Strand displacement RT-PCR uses a random (at the 3' end) primer and an amplification 
primer. The sequence of the random primer was (AGCGGGGGTTGTCGAATGTTTGANNNN) and 
the sequence of the amplification primer was (AGCGGGGGTTGTCGAATGTTTGA). The RT-PCR 
reaction was carried out using the TaKaRa RNA LA PCR kit (Takara Bio. Inc., Otsu, Shiga, Japan) 
according to the manufacturer’s protocol. A DNA Engine Peltier thermocycler (Bio-Rad Laboratories 
Inc., Hercules, CA, USA) was used for the RT reaction, which included an RNA denaturing step at 
65 °C for 10 min followed by 30 °C for 10 min, 42 °C for 60 min, 99 °C for 5 min, and 5 °C for 5 min. Viruses 2011, 3              
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The PCR reaction was run on the same machine as the RT step and included a one-time initial 
denaturation step of 94 °C for 2 min, followed by 30 cycles of 94 °C for 30 s, 60 °C for 30 s and 72 °C 
for 3 min. 
The PCR products were agarose gel purified using the QIAquick gel extraction kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s protocol. The PCR products were cloned into the 
TOPOXL vector using the TOPOXL cloning kit (Invitrogen, Carlsbad, CA, USA) according to 
manufacturer’s protocol to prepare cDNA libraries for sequencing.  
Plasmid DNA from the libraries of the cloned cDNA fragments for each virus was isolated using an 
alkaline lysis method modified for the 96-well format and incorporating both Hydra and Tomtek 
robots. Sequencing reactions were performed using the BigDye™ Terminator® Cycle Sequencing Kit 
Version 3.1 (Applied Biosystems, Foster City, CA, USA) and MJ Research (Watertown, MA, USA) 
thermocyclers. Sephadex filter plates were used to filter each reaction into Perkin-Elmer MicroAmp 
Optical 96-well plates. A 1/12-strength sequencing reaction on an ABI 3730 was used to sequence 
each clone from both the 5' and 3' ends.  
Primers for one-step RT-PCR were specifically designed for each virus (Supplemental Table 2). 
Viral RNA was amplified using the Titan One Tube RT-PCR kit (Roche Diagnostics, Indianapolis, IN, 
USA) following manufacturer’s instructions. A DNA Engine Peltier Thermocycler (Bio-Rad 
Laboratories, Inc., Hercules, CA, USA) was used for the RT-PCR reaction, which had the following 
steps: one cycle of 42 °C for 60 min and 95 °C for 5 min, followed by 10 cycles of 94 °C for 30 s, 
50 °C for 30 s, and 68 °C for 1 min 30 s, and then 25 cycles of 94 °C for 30 s, 50 °C for 30 s,  
68 °C for 1 min and 30 s adding 5 s with each cycle.  
The resulting PCR products were agarose gel purified using the QIAquick gel extraction kit 
(Qiagen, Valencia, CA, USA) according to the manufacturer’s protocol. The resulting cDNA was 
sequenced using ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied 
Biosystems, Foster City, CA, USA) following the manufacturer’s protocol. The reactions were 
prepared for sequencing by centrifugation through either a Centri-Sep column (Applied Biosystems, 
Foster City, CA, USA) or using the Edge system (EdgeBio, Gaithersburg, MD, USA) plate. The 
samples were sequenced at the Georgia Genomics Facility (University of Georgia, Athens, GA, USA). 
4.3. Genome Assembly and Analysis 
Chromatogram files and trace data were read and assembled using SeqMan Pro, and genome 
annotation was conducted with SeqBuilder (DNASTAR, Inc., Madison, WI, USA). Each sequence was 
aligned to a representative genome; Mass/Mass41/41 (GenBank accession #AY851295), or 
CAL99/CAL99/99 (GenBank accession #AY514485) as a backbone for genome assembly. 
Whole genome analyses were generated and phylogenetic trees constructed with the Neighbor-
Joining method with 1000 bootstrap replicates as well as with Minimum Evolution, Maximum 
Parsimony and UPGMA methods [17].  
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4.4. GenBank Accession Numbers 
Virus genome sequences generated in this study were submitted to GenBank and assigned the 
following accession numbers: CAV/CAV56b/91 (GU393331), DE/DE072/92 (GU393332), 
FL/FL18288/71 (GU393333), Gray/Gray/60 (GU393334), Mass/H120 (GU393335), Holte/Holte/54 
(GU393336), Iowa/Iowa97/56 (GU393337), JMK/JMK/64 (GU393338). 
GenBank accession numbers for full-length sequences used as reference in this study are: 
Mass/Mass41/41 (AY851295), Mass/H52 (EU817497), Ark/Ark-DPI-p11/81 (EU418976), Ark-DPI-
p101/91 (EU418975), CAV/CAV99/99 (AY514485), CK/CH/EP3 (DQ001338), CK/CH/p65 
(DQ001339), Mass/Beaudette (NC_001451), NGA/A116E7/06 (FN430415), ITA/90254/05 
(FN430414), TW/TW2575/98 (DQ646405), CK/CH/SC021202/02 (EU714029), CK/CH/ZJ971/97 
(EU714028), CK/CH/BJ/97 (AY319651), CK/CH/SAIBK (DQ288927), CK/CH/LSD/051/06 
(EU637854), CK/CH/DY07/07 (HM245923), CK/CH/CQ04-1/04 (HM245924), GA98/GA98/98 
(GQ504723), PeafowlCcV/GD/KQ6/03 (AY641576), PartridgeCoV/GD/S14/03 (AY646283), 
TCoV/IN-540/94 (EU022525), TCoV/MN-ATCC (EU22526), TCoV/VA-74/03 (GQ427173), 
TCoV/TX-GL/01 (GQ427174), TCoV/IN-517/94 (GQ427175), TCoV/TX-1038/98 (GQ427176), 
TCoV/Canada-MG10 (EU095850) BulbulCoV/HKU11/09 (FJ376619), ThrushCoV/HKU12/09 
(FJ376621), MuniaCoV/HKU13/09 (FJ376622), BelugaWhaleCoV/SW1/08 (NC_010646), 
FCoV/FIPV/WSU-79/1146 (DQ010921). 
4.5. Detection of Networked Relationships and Recombination Break Points  
We used Neighbor-net analysis to examine the IBV genomes for evidence of networked 
relationships and the pairwise homoplasy index (PHI) in SplitsTree (Version 4, Simmonics, University 
of Warwick, Coventry, UK) [20,38,39] to statistically determine the likelihood of recombination. In 
addition, the IBV genomes were examined for recombination breakpoints using the Recombination 
Detection Program (RDP4, Version 4, Simmonics, University of Warwick, Coventry, UK) [21,22]. 
Unless otherwise stated, default settings were used in all of the programs. The specific algorithms used 
were RDP [40], GENECONV [41], BOOTSCAN/RESCAN [40], MAXIMUM CHI SQUARE [42], 
CHIMAERA [43], SISCAN [44], and 3Seq [45]. We used more than one method to analyze the data 
because evaluation of these recombination detection methods using both simulated and empirical data 
showed that the results from only a single method were not very reliable [46]. Automasking was used 
for optimal recombination detection. The RDP analysis was run without a reference and a window size 
of 60, BOOTSCAN window size was increased to 500, MAXCHI and CHIMAERA number of 
variable sites per window was increased to 120, and the window size and step size for SISCAN was 
increased to 500 and 20, respectively. The window sizes were increased from their default settings 
because IBV has a high mutation rate, which can mask recombination signals. Increasing the window 
size was shown to increase the ratio of recombination signals relative to mutational “noise” [47]. 
4.6. Phylogenic Analysis of Sequential Genome Fragments 
Inconsistent phylogenetic relationships between different regions of the viral genome provide 
further evidence of genetic recombination. Herein, we examined the order of avian gamma-coronavirus Viruses 2011, 3              
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IBV strains in phylogenetic trees generated from sequential genome fragments using TreeOrder Scan 
(Version 1.6, Simmonics, University of Warwick, Coventry, UK) [26,27]. Changes in the tree position 
of taxa supported at the 70% or greater bootstrap level for a 250 bp sequence window were examined 
at 100  bp intervals. In addition, a phylogenetic compatibility matrix was constructed and used to 
examine the frequency and location of recombinations across the entire genome.  
4.7. Recombination Site Detection 
Potential recombination sites were identified using the RDP4 software [22] and a breakpoint map 
was constructed. A breakpoint density plot was then created from this map by moving a 200 nt 
window 1 nt at a time along the length of the map. The number of breakpoints falling within a window 
was plotted at the central window position. A 99% (upper) and 95% (lower) confidence threshold for 
globally significant breakpoint clusters (defined as windows with more breakpoint positions than the 
maximum found in >95% of the 1,000 permuted plots) was calculated. In addition, 99% and 95% 
confidence intervals were calculated for local breakpoint clusters (defined as windows with more 
breakpoint positions than the maximum found in >99% of the windows at that location in 1,000 
permuted plots). 
Acknowledgements 
This work was supported by USDA, CSREES award number 2007-35600-17786. The authors 
would like to thank the technical help of Jon S. Robertson and Cornelia Lemke with sequencing. 
References and Notes 
1.  Lai, M.M.C.; Holmes, K.V. Coronaviridae: The viruses and their replication. In Fields Virology, 
4th ed.; Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., 
Straus, S.E., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2001; Volume 1,   
pp. 1163–1185. 
2.  Cavanagh, D.; Mawditt, K.; Adzhar, A.; Gough, R.E.; Picault, J.P.; Naylor, C.J.; Haydon, D.; 
Shaw, K.; Britton, P. Does IBV change slowly despite the capacity of the spike protein to vary 
greatly? Adv. Exp. Med. Biol. 1998, 440, 729–734. 
3.  Niesters, H.G.; Kusters, J.G.; Lenstra, J.A.; Spaan, W.J.; Horzined, M.C.; van der Zeijst, B.A. The 
neutralization epitopes on the spike protein of infectious bronchitis virus and their antigenic 
variation. Adv. Exp. Med. Biol. 1987, 218, 483–492. 
4. Holmes,  E.C.  The Evolution and Emergence of RNA Viruses, 1st ed.; Oxford University Press 
Inc.: New York, NY, USA, 2009. 
5.  Lai, M. RNA Recombination in animal and plant viruses. Microbiol. Rev. 1992, 56, 61–79. 
6.  Kusters, J.G.; Jager, E.J.; Niesters, H.G.M.; van der Zeijst, B.A.M. Sequence evidence for RNA 
recombination in field isolates of avian coronavirus infectious bronchitis virus. Vaccine 1990, 8, 
605–608. 
7.  Jia, W.; Karaca, K.; Parrish, C.R.; Naqi, S.A. A novel variant of avian infectious bronchitis virus 
resulting from recombination among three different strains. Arch. Virol. 1995, 140, 259–271. Viruses 2011, 3              
 
 
1797
8.  Lee, C.W.; Jackwood, M.W. Origin and evolution of Georgia 98 (GA98), a new serotype of avian 
infectious bronchitis virus. Virus Res. 2001, 80, 33–39. 
9.  Lee, C.W.; Jackwood, M.W. Evidence of genetic diversity generated by recombination among 
avian coronavirus IBV. Arch. Virol. 2000, 145, 2135–48. 
10.  Estevez, C.; Villegas, P.; El-Attrache, J. A recombination event, induced in ovo, between a low 
passage infectious bronchitis virus field isolate and a highly embryo adaptedvaccine strain. 
Avian Dis. 2003, 47, 1282–1290. 
11. Mardani, K.; Noormohammadi, A.H.; Ignjatovic, J.; Browning, G.F. Naturally occurring 
recombination between distant strains of infectious bronchitis virus. Arch. Virol. 2010, 155,  
1581–1586. 
12.  Woo, P.C.; Lau, S.K.; Huang, Y.; Yuen, K.Y. Coronavirus diversity, phylogeny and interspecies 
jumping. Exp. Biol. Med. 2009, 234, 1117–1127. 
13.  Decaro, N.; Mari, V.; Campolo, M.; Lorusso, A.; Camero, M.; Elia, G.; Martella, V.; Cordioli, P.; 
Enjuanes, L.; Buonavoglia, C. Recombinant canine coronaviruses related to transmissible 
gastroenteritis virus of Swine are circulating in dogs. J. Virol. 2009, 83, 1532–1537. 
14.  Jackwood, M.W.; Boynton, T.O.; Hilt, D.A.; McKinley, E.T.; Kissinger, J.C.; Paterson, A.H.; 
Robertson, J.; Lemke, C.; McCall, A.W.; Williams, S.M.; Jackwood, J.W.; Byrd, L.A. Emergence 
of a group 3 coronavirus through recombination. Virology 2010, 398, 98–108. 
15.  Lee, C.W.; Hilt, D.A.; Jackwood, M.W. Identification and analysis of the Georgia 98 serotype, a 
new serotype of infectious bronchitis virus. Avian Dis. 2001, 45, 164–172. 
16.  National Center for Biotechnology Information. Available online: http://www.ncbi.nlm.nih.gov/ 
(accessed on 15 February 2011). 
17.  Tamura, K.; Dudley, J.; Nei, M.; Kumar, S. MEGA4: Molecular evolutionary genetics analysis 
(MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24, 1596–1599. 
18. Woo, P.C.Y.; Huang, Y.; Lau, S.K.; Yuen, K.Y. Coronavirus genomics and bioinformatics 
analysis. Viruses 2010, 2, 1804–1820. 
19.  Worobey, M.; Holmes, E.C. Evolutionary aspects of recombination in RNA viruses. J. Gen. Virol. 
1999, 80, 2535–2543. 
20.  Bruen, T.C.; Philippe, H.; Bryant, D. A simple and robust statistical test for detecting the presence 
of recombination. Genetics 2006, 172, 2665–2681. 
21.  Heath, L.; van der Walt, E.; Varsani, A.; Martin, D.P. Recombination patterns in aphthoviruses 
mirror those found in other picornaviruses. J. Virol. 2006, 80, 11827–11832. 
22.  Martin, D.P. Recombination detection and analysis using RDP3. Methods Mol. Biol. 2009, 537, 
185–205. 
23.  Zhang, Y.; Wang, H.-N.; Wang, T.; Fan, W.-Q.; Zhang, A.-Y.; Wei, K.; Tian, G.-B.; Yang, X. 
Complete genome sequence and recombination analysis of infectious bronchitis virus attenuated 
vaccine strain H120. Virus Genes 2010, 41, 377–388. 
24.  Hein, R. Poultry Health Consultant, Georgetown, DE, USA, Personal Communication, 2010. 
25. Woo, P.C.Y.; Lau, S.K.P.; Yip, C.C.Y.; Huang, Y.; Tsoi, H-W.; Yuen, K-Y. Comparative 
analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural 
recombination in coronavirus HKU1. J. Virol. 2006, 80, 7136–7145. Viruses 2011, 3              
 
 
1798
26.  Simmonds, P.; Welch, J. Frequency and dynamics of recombination within different species of 
human enteroviruses. J. Virol. 2006, 80, 483–493. 
27. Simmonds, P.; Midgley, S. Recombination in the genesis and evolution of hepatitis B virus 
genotypes. J. Virol. 2005, 79, 15467–15476. 
28. Armesto, M.; Cavanagh, D.; Britton, P. The replicase gene of avian coronavirus infectious 
bronchitis virus is a determinant of pathogenicity. PLoS One 2009, 4, e7384. 
29.  Hagemeijer, M.C.; Verheije, M.H.; Ulasli, M.; Shaltiel, I.A.; de Vries, L.A.; Reggiori, F.; Rottier, 
P.J.; de Haan, C.A. Dynamics of coronavirus replication-transcription complexes. J. Virol. 2010, 
84, 2134–2149. 
30. Lindner, H.A.; Fotouhi-Ardakani, N.; Lytvyn, V.; Lachance, P.; Sulea, T.; Menard, R. The 
papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating 
enzyme. J. Virol. 2005, 79, 15199–15208. 
31.  Zheng, D.; Chen, G.; Guo, B.; Cheng, G.; Tang, H. PLP2, a potent deubiquitinase from murine 
hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008, 18,  
1105–1113. 
32.  Gorbalenya, A.E.; Koonin, E.V.; Donchenko, A.P.; Blinov, V.M. Coronavirus genome: Prediction 
of putative functional domains in the non-structural polyprotein by comparative amino acid 
sequence analysis. Nucleic. Acids Res. 1989, 17, 4847–4861. 
33.  Gorbalenya, A.E.; Koonin, E.V.; Lai, M.M. Putative papain-related thiol proteases of positive-strand 
RNA viruses. Identification of rubi- and aphthovirus proteases and delineation of a novel conserved 
domain associated with proteases of rubi-, alpha- and coronaviruses. FEBS Lett. 1991, 288, 201–205. 
34. Eriksson, K.K.; Cervantes-Barragan, L.; Ludewig, B.; Thiel, V. Mouse hepatitis virus liver 
pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-
like supergroup. J. Virol. 2008, 82, 12325–12334. 
35.  Zhang, X.W.; Yap, Y.L.; Danchin, A. Testing the hypothesis of a recombinant origin of the 
SARS-associated coronavirus. Arch. Virol. 2005, 150, 1–20. 
36.  Chen, X.; Zhang, Q.; Li, J.; Cao, W.; Zhang, J.X.; Zhang, L.; Zhang, W.; Shao, Z.J.; Yan, Y. Analysis 
of recombination and natural selection in human enterovirus 71. Virology 2010, 398, 251–261. 
37.  Gelb, J.J.; Jackwood, M.W. Infectious Bronchitis. In A Laboratory Manual for the Isolation, 
Identification, and Characterization of Avian Pathogens, 5th ed.; Dufour-Zavala, L., Swayne, 
D.E., Glisson, J.R., Pearson, J.E., Reed, W.M., Jackwood, M.W., Woolcock, P., Eds.; American 
Association of Avian Pathologists: Kennett Square, PA, USA, 2008, pp 146–149. 
38.  Huson, D.H.; Bryant, D. Application of phylogenetic networks in evolutionary studies. Mol. Biol. 
Evol. 2006, 23, 254–267. 
39. Bryant, D.; Moulton, V. Neighbor-net: An agglomerative method for the construction of 
phylogenetic networks. Mol. Biol. Evol. 2004, 21, 255–265. 
40.  Martin, D.P.; Posada, D.; Crandall, K.A.; Williamson, C. A modified bootscan algorithm for 
automated identification of recombinant sequences and recombination breakpoints. AIDS Res. 
Hum. Retroviruses 2005, 21, 98–102. 
41.  Padidam, M.; Sawyer, S.; Fauquet, C.M. Possible emergence of new geminiviruses by frequent 
recombination. Virology 1999, 265, 218–225. 
42.  Smith, J.M. Analyzing the mosaic structure of genes. J. Mol. Evol. 1992, 34, 126–129. Viruses 2011, 3              
 
 
1799
43. Posada, D.; Crandall, K.A. Evaluation of methods for detecting recombination from DNA 
sequences: Computer simulations. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 13757–61372. 
44.  Gibbs, M.J.; Armstrong, J.S.; Gibbs, A.J. Sister-scanning: A Monte Carlo procedure for assessing 
signals in recombinant sequences. Bioinformatics 2000, 16, 573–582. 
45.  Boni, M.F.; Posada, D.; Feldman, M.W. An exact nonparametric method for inferring mosaic 
structure in sequence triplets. Genetics 2007, 176, 1035–1047. 
46.  Posada, D. Evaluation of methods for detecting recombination from DNA sequences: Empirical 
data. Mol. Biol. Evol. 2002, 19, 708–717. 
47. Salminen, M.A.M. Detecting and characterising individual recombination events: practice. In 
The Phylogenetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing; 
Lemey, P., Salemi, M., Vandamme, A.M., Eds.; Cambridge University Press: Cambridge, UK, 2010; 
p. 723. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 